Linkedin
Search
Close this search box.
See it in Action
Linkedin
See it in Action
Linkedin
Search
Close this search box.
See it in Action
Linkedin

Doing useful things – Cover Story

Read the Cover Story at the MedEdge, May – June 2024, Page 6 form our CEO Dr. Ali Tinazli

MedEdge, May-June 2024

Follow us on LinkedIn
Back to News

More from press and media

lifespin GmbH and Acibadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine

May 28, 2024
Regensburg, Germany; Istanbul, Turkey, May 28th 2024 – lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and ...
Read More

Interview with Dr. Ali Tinazli at “The Health 2.0 Conference” in Dubai 2024

April 5, 2024
Interview with Dr. Ali Tinazli at Health 2.0 Conference
Read More

Q&A: Lifespin’s Dr. Ali Tinazli on metabolomics, the Middle East & making precision medicine affordable

February 19, 2024
Q&A with Dr. Ali Tinazli
Read More

The dawn of the digital twin in precision medicine

February 13, 2024
Article about lifespin at the PrecisionMed International Magazine
Read More

Deep Health Information for Transformational Change in Democratizing Precision Medicine

January 12, 2024
Article about lifespin at the MedEdge
Read More

Lifespin’s Innovative Therapeutic Drug Monitoring Panel

January 12, 2024
Lifespin's Innovative Therapeutic Drug Monitoring Panel: A Key Step in Precision Health and Antibiotic Resistance Control
Read More

Interview with Dr. Ali Tinazli at MedTech Insights

September 20, 2023
Interview "Spinning Around – One Company's Bid To Diagnostic-ify The Metabolism"
Read More

Interview with Dr. Ali Tinazli at “The Health 2.0 Conference” in Dubai

August 23, 2023
Interview with Dr. Ali Tinazli at Health 2.0 Conference
Read More
Health Data Revolution – Digital
Transformation of Metabolomics
lifespin GmbH
Am Biopark 13
93053 Regensburg
Germany
T: +49 941/942 898 0
E: info@lifespin.health
Linkedin
Copyright © 2024 lifespin GmbH | All Rights Reserved.
Distribution, Citation or Copying Without Permission is Strictly Prohibited.

Disclaimer: lifespin’s products are for Research Use Only (RUO) and currently are not for use in diagnostic procedures. lifespin Products have not been evaluated or approved by the FDA or any other regulatory authority. None of these statements have been endorsed by the FDA or any other regulatory authority. None of the products discussed in this material are currently being sold or offered for sale.

Scroll to Top

Dr. Roland Geyer

COO
10+ years experience in NMR-based metabolomics and diagnostic.
  • Background in medicinal chemistry
  • Built and headed the life sciences department at numares AG
  • Pioneered NMR-based metabolic profiling
  • Successfully implemented 30+ R&D projects for analytical methods, software and systems

Dr. Renate Kirchhöfer

CDO & Co-Founder
20+ years developing NMR-applications and bringing them to regulated markets.
  • Background in Biophysics, computer sciences and NMR. Several patents in this field.
  • Member of the board of lipofit GmbH and numares AG. Establishing internationalization.
  • Co-founded lifespin GmbH in 2017. Setting up company structures.

Dr. Fritz Huber

CEO & Co-Founder
20+ years developing and marketing NMR-based assays—he is a pioneer in this field.
  • Plasma physics, MPI Garching
  • In 2004 he co-founded LipoFIT GmbH, served as its manager, transforming it into numares AG—growing the company into an international operation
  • Co-founded lifespin GmbH in 2017

Dr. Ali Tinazli

CEO, lifespin GmbH
Linkedin Envelope

15+ years in Fortune 100 corporate strategy and entrepreneurship (SONY, HP).

  • Built HP’s global healthcare strategy
  • Commercialized first IVD product for billionaire-funded Fluxergy
  • Board member (e.g. Edico Genome acquired by Illumina)